Healthcare Insurance Marketing Security 
Security Affairs
JANUARY 6, 2024
Merck has resolved a dispute with insurers regarding a $1.4 Merck and its insurers have agreed with a $1.4 known as Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company. billion insurance claim for the losses caused by the NotPetya attack that took place in 2017.
Security Affairs
DECEMBER 1, 2020
The CyberNews investigation team discovered French pharmaceuticals distribution platform Apodis Pharma leaking 1.7+ Apodis Pharma is a company that offers a digital supply chain management platform and other software solutions created for pharmacies, healthcare institutions, pharmaceutical laboratories, and health insurance companies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Security Ledger
AUGUST 20, 2019
We talk to Bruce McDonnell of the East West Institute about how insurers are responding. Related Stories Episode 155: Disinformation is a Cyber Weapon and APTs warm to Mobile Malware Podcast Episode 117: Insurance Industry Confronts Silent Cyber Risk, Converged Threats NotPetya Horror Story Highlights Need for Holistic Security.
Krebs on Security
JUNE 1, 2023
This post is a deep dive on “ Megatraffer ,” a veteran Russian hacker who has practically cornered the underground market for malware focused code-signing certificates since 2015. One of Megatraffer’s ads on an English-language cybercrime forum. “Why do I need a certificate? At least my laptop is sure of it.”
Data Matters
SEPTEMBER 20, 2021
The National Association of Insurance Commissioners (NAIC) held its Summer 2021 National Meeting (Summer Meeting) August 14-17, 2021. Highlights include, among others, adoption of revised risk-based capital bond factors for life insurers, amendments to SSAP No. NAIC Adopts Revised Risk-Based Capital Bond Factors for Life Insurers.
IT Governance
SEPTEMBER 4, 2018
Organisations rely on their IP to retain a competitive position in the market. For life sciences and pharmaceutical companies, this includes data on the development and testing of new therapies and details of how therapies are manufactured. IP includes sensitive business or trading information and research and development information.
Reltio
SEPTEMBER 13, 2022
In today's uncertain market and economic environments, our customers must ensure that Reltio solves their most pressing data challenges while saving money, growing revenue, reducing risk, and creating efficiencies. Customers interviewed in the study were from the pharmaceuticals, technology, insurance and retail industries.
Expert insights. Personalized for you.
117 
Let's personalize your content